Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PPDI - Pharmaceutical Product Development, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Phaedrus who wrote (1)	1/22/1998 5:18:00 PM
From: Steve Morytko	Read Replies (1) \| Respond to of 71

I only know what I've read at the URL below. Perhaps they'll comment further upon reporting earnings. The fact that it's an exclusive agreement could work against them if IBM doesn't do anything with it (they don't exactly have a stellar record with some of their own acquisitions - Lotus?). It would be interesting to know how well IBM does selling their pharmaceutical software. If it's successful PPDI could have a big win. Hope they did their homework. Any idea when earnings will be reported and/or conference call numbers? ppdpharmaco.com

To: Phaedrus who wrote (1)	1/30/1998 5:12:00 PM
From: Fleetwood	Read Replies (1) \| Respond to of 71

Phaedrus, The software products involved in the IBM/PPDI reseller agreement are: the CrossGraphs(R) data visualization and graphical reporting system the TableTrans(tm) visual database transformation system Belmont Research is the software consulting and software products division of PPDI. Additional information about these products is available at the Belmont Research home page: belmont.com You can also contact me, at the address below: Regards, Jim Ong Director, Product Marketing Belmont Research jong@belmont.com